Aubé J (2012) Drug repurposing and the medicinal chemist. ACS Med Chem Lett 3(6):442–444.

https://doi.org/10.1021/ml300114c

Baron JA (2012) Aspirin and cancer: trials and observational studies. J Natl Cancer Inst 104(16):

1199–1200. https://doi.org/10.1093/jnci/djs338

Boran AD, Iyengar R (2010) Systems approaches to polypharmacology and drug discovery. Curr

Opin Drug Discov Dev 13(3):297–309

Bottegoni G, Favia AD, Recanatini M, Cavalli A (2012) The role of fragment-based and computa-

tional methods in polypharmacology. Drug Discov Today 17(1–2):23–34. https://doi.org/10.

1016/j.drudis.2011.08.002

Chen YZ, Ung CY (2001) Prediction of potential toxicity and side effect protein targets of a small

molecule by a ligand–protein inverse docking approach. J Mol Graph Model 20(3):199–218.

https://doi.org/10.1016/S1093-3263(01)00109-7

Chen YZ, Zhi DG (2001) Ligand–protein inverse docking and its potential use in the computer

search of protein targets of a small molecule. Proteins Struct Funct Bioinform 43(2):217–226.

https://doi.org/10.1002/1097-0134(20010501)43:2<217::AID-PROT1032>3.0.CO;2-G

Cheng D, Knox C, Young N, Stothard P, Damaraju S, Wishart DS (2008) PolySearch: a web-based

text mining system for extracting relationships between human diseases, genes, mutations,

drugs and metabolites. Nucleic Acids Res 36(suppl 2):W399–W405. https://doi.org/10.1093/

nar/gkn296

Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV

(1997) Valvular heart disease associated with fenfluramine–phentermine. N Engl J Med 337(9):

581–588. https://doi.org/10.1056/NEJM199708283370901

Dar AC, Das TK, Shokat KM, Cagan RL (2012) Chemical genetic discovery of targets and anti-

targets for cancer polypharmacology. Nature 486(7401):80. https://doi.org/10.1038/

nature11127

DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M (2004) Efficacy and

safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease.

Am J Cardiol 93(2):147–153. https://doi.org/10.1016/j.amjcard.2003.09.030

Du-Cuny L, Chen L, Zhang S (2011) A critical assessment of combined ligand-and structure-based

approaches to HERG channel blocker modeling. J Chem Inf Model 51(11):2948–2960. https://

doi.org/10.1021/ci200271d

Hopkins AL (2007) Network pharmacology. Nat Biotechnol 25(10):1110. https://doi.org/10.1038/

nbt1007-1110

Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1(9):727. https://doi.

org/10.1038/nrd892

Huang ZX, Tian HY, Hu ZF, Zhou YB, Zhao J, Yao KT (2008) GenCLiP: a software program for

clustering gene lists by literature profiling and constructing gene co-occurrence networks related

to custom keywords. BMC Bioinform 9(1):308. https://doi.org/10.1186/1471-2105-9-308

Jenkins JL, Glick M, Davies JW (2004) A 3D similarity method for scaffold hopping from known

drugs or natural ligands to new chemotypes. J Med Chem 47(25):6144–6159. https://doi.org/10.

1021/jm049654z

Jenwitheesuk E, Horst JA, Rivas KL, Van Voorhis WC, Samudrala R (2008) Novel paradigms for

drug discovery: computational multitarget screening. Trends Pharmacol Sci 29(2):62–71.

https://doi.org/10.1016/j.tips.2007.11.007

Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK (2007) Relating protein

pharmacology by ligand chemistry. Nat Biotechnol 25(2):197. https://doi.org/10.1038/nbt1284

Koutsoukas A, Simms B, Kirchmair J, Bond PJ, Whitmore AV, Zimmer S, Young MP, Jenkins JL,

Glick M, Glen RC, Bender A (2011) From in silico target prediction to multi-target drug design:

current databases, methods and applications. J Proteome 74(12):2554–2574. https://doi.org/10.

1016/j.jprot.2011.05.011

Krauthammer M, Kaufmann CA, Gilliam TC, Rzhetsky A (2004) Molecular triangulation: bridging

linkage and molecular-network information for identifying candidate genes in Alzheimer’s

24

T. R. Sahrawat and R. C. Sobti